Ali Homaei

Dr. Ali Homaei


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
AHAmir Human Hoveidaei
Amir Human Hoveidaei
ARArian Rahimzadeh
Arian Rahimzadeh
SMSara Mohammadi
Sara Mohammadi
PTPranav Thota
Pranav Thota
KVKimia Vakili
Kimia Vakili
JCJanet D Conway
Janet D Conway
Osteomyelitis (OM), an inflammatory condition of the bone tissue, is a complex orthopedic condition marked by chronic inflammation, diagnostic uncertainty, and recurrent infections. Despite standard treatments—including surgical debridement, antimicrobial therapy, and bone reconstruction—many patients continue to experience recurrence and treatment failure. Growing molecular evidence indicates that host genetic factors play a crucial role in shaping immune responses and influencing disease progression in OM. This narrative review synthesizes current knowledge from candidate gene single-nucleotide polymorphism (SNP) association studies to illustrate how specific genetic variations contribute to OM pathogenesis, diagnostic refinement, and treatment outcomes. We examined key immunogenetic variants within genes involved in inflammatory signaling, pathogen recognition, and neutrophil regulation. Our synthesis identifies a landscape of pro-inflammatory SNPs, such as IL-1β rs16944 and NLRP3 rs10754558, that are associated with increased susceptibility to chronic or post-traumatic OM, as well as SNPs that are associated with protective effects that may favor infection resolution, such as within the NOS2 and VDR genes. These SNP-driven differences in inflammasome activity, cytokine pathways, and oxidative stress responses highlight emerging opportunities for individualized therapeutic strategies. This review consolidates these variants, providing a genetic framework to analyze host susceptibility and differentiating high risk from protective genetic profiles. Integrating genomic insights into OM management represents a promising shift toward personalized medicine, enhancing diagnostic precision, informing targeted interventions, and improving prognostic assessment. Continued large-scale validation of candidate SNPs and translational genomic models will be essential to support their future clinical application.

30 December 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
AHAbolfazl Heidari
Abolfazl Heidari
AHAli Homaei
Ali Homaei
FSFatemeh Saffari
Fatemeh Saffari
Osteoporosis-pseudoglioma syndrome (OPPG) is a rare autosomal recessive disorder characterized by severe osteoporosis and eye abnormalities that lead to vision loss. In this study, clinical findings and genetic study of two siblings with OPPG are presented. Whole exome sequencing of DNA enriched for exonic regions was performed with SureSelect 38Mbp all exon kit v. 7.0. The two siblings presented with different clinical manifestations of OPPG. The younger female sibling had blindness and severe osteoporosis with multiple fractures, while her older brother was also blind but with less severe osteoporosis and no fractures. On analysis, a novel homozygous nonsense mutation (c.351G>A) in exon 2 of LRP5 (NM_002335) was found, predicted to change a tryptophan at 117 to a stop codon (p. Trp117Ter). Thus, a variable phenotype was associated with an identical variant in these two siblings. The novel mutation reported herein expands the spectrum of the underlying genetic pathology of OPPG.

31 March 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SGShoaib Ahmad Goraya
Shoaib Ahmad Goraya
PLPauline Lauwers
Pauline Lauwers
HJHoda Javadikasgari
Hoda Javadikasgari
ARAmir Rouhollahi
Amir Rouhollahi
AHAli Homaei
Ali Homaei
FNFarhad Nezami
Farhad Nezami
Background: Women with severe aortic stenosis (AS) are diagnosed later and experience poorer outcomes than men, partly because clinical approaches rely on 2D, valve-centric thresholds derived from male-predominant cohorts that underutilize information from 3D left ventricular (LV) geometry. We hypothesize that a sex-specific computational framework integrating statistical shape analysis (SSA) of pre-TAVR CT with machine learning would improve prediction of 1-year LV mass regression (LVMR). Objective: To develop a computational framework leveraging 3D LV geometry and evaluate whether it improves sex-specific prediction of 1-year LVMR after TAVR. Methods: We studied 339 patients with severe AS who underwent TAVR from 2013 to 2020 and had pre-TAVR CT and 1-year post-TAVR echocardiography. LV geometries were segmented into digital twins, and shape modes predictive of LVMR were extracted using SSA and partial least squares. These modes were incorporated into support vector regression models and compared with conventional echocardiographic predictors, including pre-TAVR LVEF, LVMI, and E/A ratio. Performance was assessed using RMSE and R 2 . Results: After one year, 65% of patients showed positive LVMR, with median regression of approximately 10%; regression was significant overall and within each sex ( p < 0.001) and similar between sexes ( p = 0.99). Predictive shape modes differed by sex ( p < 0.01), with women showing more localized variation and men broader geometric gradients. Sex-specific shape modes outperformed general modes and clinical metrics, particularly in women (R 2 = 0.80, RMSE = 0.09 vs. R 2 = 0.59, RMSE = 0.13; clinical-only baseline R 2 = 0.16, RMSE = 0.22). In men, sex-specific modes also performed strongly (R 2 = 0.89, RMSE = 0.08). Conclusion: In severe AS, 3D LV geometry predicts post-TAVR reverse remodeling more accurately than conventional metrics and may improve risk stratification, particularly in women.

4 September 2026 in Journal of Surgical Education
Verified
Journal Article
Closed access
SWSue X. Wang
Sue X. Wang
VWVivian Wang
Vivian Wang
SMShahab Masoumi
Shahab Masoumi
AHAli Homaei
Ali Homaei
JLJoon Haeng Lee
Joon Haeng Lee
BSBorami Shin
Borami Shin

3 November 2026 in Journal of the American Heart Association
Verified
Journal Article
Closed access
BKBoateng Kubi
Boateng Kubi
AHAli Homaei
Ali Homaei
AKAlina Keshwani
Alina Keshwani
RBRohin Bajaj
Rohin Bajaj
EOEmmanuel Odekunle
Emmanuel Odekunle
MHMotahar Hosseini
Motahar Hosseini
Background: We evaluated postoperative neurologic and mortality outcomes by stroke‐to‐surgery timing and stroke phenotype in patients with left‐sided infective endocarditis. Methods: Adult patients undergoing surgery for infective endocarditis complicated by preoperative stroke between 2004 and 2024 at 2 institutions were stratified by stroke‐to‐surgery interval (<1 week, 1–4 weeks, 4–6 weeks). The primary outcome was a composite postoperative cerebrovascular event: new stroke, enlarging stroke, or hemorrhagic conversion. Secondary outcomes were operative death and major morbidity events. Results: Among 2265 patients with left‐sided infective endocarditis, 322 met inclusion criteria, of whom 122 (38%) underwent surgery within 1 week, 168 (52%) between 1 and 4 weeks, and 32 (10%) between 4 and 6 weeks. Operative death was similar across groups ( P =0.09). Postoperative cerebrovascular events declined with time (<1 week, 21.3%; 1–4 weeks, 11.9%; 4–6 weeks, 9.4%; P =0.015). On multivariable analysis, longer stroke‐to‐surgery interval was associated with reduced odds of postoperative cerebrovascular events (odds ratio, 0.92/d [95% CI, 0.85–0.98]; P =0.015), driven by early events among patients with intraparenchymal hemorrhage, subarachnoid hemorrhage, and septic emboli. Among ischemic strokes, operative death was lowest with surgery within 1 week (5.8% versus 11.2% at 1–4 weeks; P =0.24). Interval embolization occurred in 10.6% of patients awaiting surgery, most commonly affecting the spleen and kidneys. Conclusions: Excess postoperative neurologic risk was concentrated within the first 7 to 10 days and driven by intraparenchymal hemorrhage, subarachnoid hemorrhage, and septic emboli; ischemic stroke showed no appreciable temporal association. Routine delay after ischemic stroke may not be necessary, while a short delay (≈7 days) for hemorrhagic and septic embolic subtypes may be reasonable when hemodynamically feasible.